These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 7216093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)].
    Dietzfelbinger H, Kaboth W.
    Med Klin; 1977 Apr 15; 72(15):654-9. PubMed ID: 853979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP, Werner E, Niechzial M.
    Arzneimittelforschung; 1987 Jan 15; 37(1A):122-9. PubMed ID: 3566867
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].
    Dietzfelbinger H, Kaboth W.
    Med Klin; 1979 Nov 30; 74(48):1818-24. PubMed ID: 395435
    [Abstract] [Full Text] [Related]

  • 9. Study of bioavailability of oral iron preparations.
    Gupta KC, Paul T, Mehta JM, Desai NK, Sanghvi B, Sheth UK.
    J Postgrad Med; 1976 Apr 30; 22(2):94-9. PubMed ID: 802126
    [No Abstract] [Full Text] [Related]

  • 10. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia.
    Adsul BB, Desai A, Gawde A, Baliga V.
    J Indian Med Assoc; 2005 Jun 30; 103(6):338-42. PubMed ID: 16225161
    [Abstract] [Full Text] [Related]

  • 11. [Bioavailability of iron in oral iron preparations. Principles of duration and dosage (author's transl)].
    Heinrich HC, Gabbe EE.
    MMW Munch Med Wochenschr; 1979 Aug 31; 121(35):1104-8. PubMed ID: 114773
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P, Müller A.
    Arzneimittelforschung; 1984 Aug 31; 34(11):1560-9. PubMed ID: 6543131
    [Abstract] [Full Text] [Related]

  • 14. [Comparative evaluation of the effectiveness of peroral treatment of patients with chronic posthemorrhagic anemia with iron-containing preparations].
    Bokarev IN, Andreeva VK, Astashenko NA, Gol'tiakova TV, Ershov VI.
    Klin Med (Mosk); 1975 Nov 31; 53(11):110-3. PubMed ID: 1223501
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of iron deficiency with orally administered delayed-action ferrous sulfate and mucoproteose].
    Schindler VH, Bielesz G.
    Wien Med Wochenschr; 1975 Mar 14; 125(11):173-6. PubMed ID: 1130090
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE, Paton TW, Cowan DH, Manuel MA, Dranitsaris G.
    CMAJ; 1989 Sep 15; 141(6):543-7. PubMed ID: 2776093
    [Abstract] [Full Text] [Related]

  • 20. Poor clinical response to enteric-coated iron preparations.
    Rudinskas L, Paton TW, Walker SE, Dotten DA, Cowan DH.
    CMAJ; 1989 Sep 15; 141(6):565-6. PubMed ID: 2776097
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.